| Literature DB >> 24069481 |
Marlene Thielecke1, Vaomalala Raharimanga, Christophe Rogier, Manuela Stauss-Grabo, Vincent Richard, Hermann Feldmeier.
Abstract
BACKGROUND: Tungiasis, a parasitic skin disease caused by the female sand flea Tunga penetrans, is a prevalent condition in impoverished communities in the tropics. In this setting, the ectoparasitosis is associated with important morbidity. It causes disfigurement and mutilation of the feet. Feasible and effective treatment is not available. So far prevention is the only means to control tungiasis-associated morbidity.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24069481 PMCID: PMC3777867 DOI: 10.1371/journal.pntd.0002426
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Figure 1Flow diagram of the study.
Figure 2View of Tanambe II village.
Houses are constructed from wood and are built on stilts (A). Roads and paths are not paved (B).
Demographic and clinical characteristic of the study population.
| Characteristic | Control group (n = 70) | Shoe group (n = 77) | Repellent group (n = 72) |
| Age in years, median (range) | 25.5 (5–73) | 26.7 (5–93) | 26.8 (5–80) |
| Male-female ratio (%) | 44/56 | 39/61 | 40/60 |
| Number of household members, median (range) | 3 (1–6) | 3 (1–7) | 4 (1–6) |
| Number of household members with tungiasis, median (range) | 3 (1–6) | 3 (1–7) | 3.5 (1–6) |
| Intensity of infestation in household members | 10.5 (2.3–33.3) | 9.8 (2.3–40.3) | 10.2 (1.7–27.3) |
| Intensity of infestation in participants | 22 (1–99) | 22 (1–179) | 16 (1–91) |
| Manipulated lesions | 83.2 (0–100) | 88.8 (0–100) | 85.4 (0–100) |
| SSAT | 4 (0–17) | 3 (0–19) | 3 (0–20) |
| SSCT | 1 (0–10) | 2 (0–8.5) | 2 (0–11.5) |
total number of viable, dead and manipulated lesions; only individuals with tungiasis.
total number of viable, dead and manipulated lesions.
the patient or a caretaker had attempted to take out the embedded sand flea; in percent of total lesions.
severity score for acute tungiasis (see material and methods).
severity score for chronic tungiasis (see material and methods).
Parasitological and clinical characteristics of study groups at baseline and during intervention.
| Point of time/group | Outcome measure | |||||||
| Intensity of infestation | P-value | Attack rate | P-value | SSAT | P-value | SSCT | P-value | |
|
| ||||||||
| Control group (n = 70) | 22 (13–33) | n.a. | 4 (3–7) | 1 (0–2) | ||||
| Shoe group (n = 77) | 22 (10–35) | 0.58 | n.a. | 3 (2–7) | 0.63 | 2 (0–3.5) | 0.18 | |
| Repellent group (n = 72) | 16 (5–31.5) | 0.36 | n.a. | 3 (1–7) | 0.50 | 2 (0–3) | 0.15 | |
|
| ||||||||
| Control group (n = 70) | 21.5 (12–35) | 4 (1–8) | 4 (2–7) | 1 (0–2) | ||||
| Shoe group (n = 77) | 18 (9–34) | 0.31 | 3 (1–6) | 0.21 | 4 (2–6) | 0.72 | 1 (0–3) | 0.36 |
| Repellent group (n = 71) | 10 (3–27) | 0.06 | 0 (0–1) |
| 2 (1–4) |
| 1 (0–2.5) | 0.35 |
|
| ||||||||
| Control group (n = 70) | 19 (11–32) | 5 (1–9) | 3 (2–7) | 1 (0–2) | ||||
| Shoe group (n = 77) | 17 (8–35) | 0.34 | 3 (1–9) | 0.62 | 3 (2–6) | 0.21 | 1 (0–3.5) | 0.52 |
| Repellent group (70) | 7.5 (2–21) |
| 0 (0–1) |
| 1 (1–3) |
| 1 (0–2.5) | 0.79 |
|
| ||||||||
| Control group (n = 70) | 18 (12–36) | 3.5 (1–9) | 4 (2–7) | 1 (0–2.5) | ||||
| Shoe group (n = 73) | 17 (7–36) | 0.67 | 2 (0–7) | 0.31 | 3 (2–6) | 0.05 | 1 (0.2.5) | 0.32 |
| Repellent group (n = 68) | 6 (1.5–18) |
| 0 (0–0) |
| 1 (0–2) |
| 1 (0–2.3) | 0.64 |
|
| ||||||||
| Control group (n = 67) | 18 (11–40) | 6 (1–11) | 4 (2–9) | 1 (0–2.5) | ||||
| Shoe group (n = 70) | 15.5 (5–41) | 0.83 | 1.5 (0–6) | 0.27 | 2 (1–5) | 0.14 | 1 (0–3) | 0.60 |
| Repellent group (n = 70) | 4.5 (1–17) |
| 0 (0–1) |
| 1 (0–2) |
| 0.8 (0–1.5) | 0.37 |
|
| ||||||||
| Control group (n = 65) | 19 (10–35) | 4 (2–8) | 4 (2–6) | 1 (0–2.5) | ||||
| Shoe group (n = 72) | 15 (6–36) | 0.85 | 2 (0–4.5) |
| 3 (1–4) | 0.11 | 1 (0–3) | 0.43 |
| Repellent group (n = 69) | 3 (1–13) |
| 0 (0–0) |
| 1 (0–1) |
| 0.5 (0–2) | 0.36 |
Data indicate the median and the interquartile range (IQR).
n. a. = not applicable.
total number of viable, dead and manipulated lesions.
shoe group versus control group, and repellent group versus control group, respectively.
number of newly penetrated sand fleas since last examination.
severity score for acute tungiasis.
severity score for chronic tungiasis.
Figure 3Total number of sand flea lesions (viable, dead and manipulated lesions during the intervention phase.
Data indicate medians.
Figure 4Number of newly penetrated sand fleas during the intervention phase.
Data indicate medians.
Figure 5Dynamics of the Severity Score for Acute Tungiasis (SSAT) during the intervention phase.
Data indicate medians.
The intensity of infestation and the attack rate in the shoe group stratified according to compliance.
| Wearing shoes | ||||||
| never/rarely (n = 14) | irregularly (n = 24) | regularly (n = 25) | never/rarely (n = 14) | irregularly (n = 24) | regularly (n = 25) | |
| Point of time | Intensity of infestation | Attack rate | ||||
| Baseline (n = 77) | 24.5 (16–55) | 18.5 (9.5–28) | 19 (11.5–29) | n. a. | n. a. | n. a. |
| Week 2 (n = 77) | 23 (15–50) | 13 (7.5–26) | 16.5 (8–27) | 2 (0–6) | 2 (1–8) | 2 (1–5.5) |
| Week 4 (n = 77) | 23 (16–62) | 12.5 (5–32) | 11 (5–30) | 5 (1–8) | 1 (1–7) | 3 (1–10) |
| Week 6 (n = 73) | 30.5 (19.5–67) | 12 (7–26) | 12 (4–32) | 4.5 (0–7) | 3 (0–4) | 1 (0–3) |
| Week 8 (n = 70) | 32 (15–77) | 10.5 (5.5–31) | 9 (3–27) | 5 (0–7) | 2 (0–8.5) | 0 (0–2) |
| Week 10 (n = 72) | 21 (15–61) | 11.5 (5.75–28.5) | 9 (4–20) | 2 (1–7) | 3 (1–7) | 0.5 (0–3) |
n. a. = not applicable.
total number of lesions.
newly penetrated sand fleas since the previous examination.
Data indicate the median and the interquartile range (IQR).
Figure 6[→ triangle indicates newly penetrated sand fleas; ▴ indicates older lesions) Picture series of an individual of the control cohort with typical clinical pathology at the sole;
(A) baseline examination, (B) week 2, (C) week 6 and (D) week 10 of follow up.
Figure 7Picture series of an individual of the shoe cohort with typical clinical pathology at the sole;
(A) baseline examination, (B) week 2, (C) week 6 and (D) week 10 of follow up.
Figure 8Picture series of an individual of the repellent cohort with typical clinical pathology at the sole;
(A) baseline examination, (B) week 2, (C) week 6 and (D) week 10 of follow up.